1 min to read News Posted on June 29, 2023 COVID Drug Maker Tevogen To Go Public Via SPAC At $1.2B – Law360 COVID Drug Maker Tevogen To Go Public Via SPAC At $1.2B Law360 Source: COVID Drug Maker Tevogen To Go Public Via SPAC At .2B – Law360 share tweet share Tags: SPACs